Konstantinos Xynos, Chief Medical Officer at Replimune Group, Inc. (REPL), sold 14,023 shares at $5.08 ($71K) on 2026-05-18, disclosed to the SEC on 2026-05-20.
Seasonal sale ($71k) by Chief Medical Officer — this insider has traded REPL in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| REPL | SELL | 2025-05-22 | $128K | — | Filing → |
| REPL | SELL | 2024-11-20 | $156K | — | Filing → |
| REPL | SELL | 2024-06-10 | $238K | — | Filing → |